BG60900B1 - Твърди лекарствени форми за орално приложение,съдържащи ифосфамид като активно вещество - Google Patents

Твърди лекарствени форми за орално приложение,съдържащи ифосфамид като активно вещество Download PDF

Info

Publication number
BG60900B1
BG60900B1 BG94934A BG9493491A BG60900B1 BG 60900 B1 BG60900 B1 BG 60900B1 BG 94934 A BG94934 A BG 94934A BG 9493491 A BG9493491 A BG 9493491A BG 60900 B1 BG60900 B1 BG 60900B1
Authority
BG
Bulgaria
Prior art keywords
weight
ifosfamide
parts
tablets
flow control
Prior art date
Application number
BG94934A
Other languages
Bulgarian (bg)
English (en)
Inventor
Dieter Sauerbier
Juergen Engel
Eckhard Milsmann
Klaus Molge
Otto Isaac
Original Assignee
Asta Medica Aktiengesellschaft
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Asta Medica Aktiengesellschaft filed Critical Asta Medica Aktiengesellschaft
Publication of BG60900B1 publication Critical patent/BG60900B1/bg

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/66—Phosphorus compounds
    • A61K31/675—Phosphorus compounds having nitrogen as a ring hetero atom, e.g. pyridoxal phosphate
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
    • A61K9/2806—Coating materials
    • A61K9/2833—Organic macromolecular compounds
    • A61K9/284—Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone
    • A61K9/2846—Poly(meth)acrylates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4841—Filling excipients; Inactive ingredients
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4841—Filling excipients; Inactive ingredients
    • A61K9/4866—Organic macromolecular compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4891—Coated capsules; Multilayered drug free capsule shells
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
BG94934A 1990-08-03 1991-08-01 Твърди лекарствени форми за орално приложение,съдържащи ифосфамид като активно вещество BG60900B1 (bg)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE4024683 1990-08-03
SG181694A SG181694G (en) 1990-08-03 1994-12-30 Solid oral administration forms containing ifosfamide as active agent

Publications (1)

Publication Number Publication Date
BG60900B1 true BG60900B1 (bg) 1996-06-28

Family

ID=25895607

Family Applications (1)

Application Number Title Priority Date Filing Date
BG94934A BG60900B1 (bg) 1990-08-03 1991-08-01 Твърди лекарствени форми за орално приложение,съдържащи ифосфамид като активно вещество

Country Status (33)

Country Link
US (1) US5158776A (no)
EP (1) EP0469440B1 (no)
JP (2) JP3061898B2 (no)
KR (1) KR0177170B1 (no)
CN (1) CN1046851C (no)
AR (1) AR247484A1 (no)
AT (1) ATE110261T1 (no)
AU (2) AU643309B2 (no)
BG (1) BG60900B1 (no)
CA (1) CA2048367C (no)
CZ (1) CZ280475B6 (no)
DE (2) DE4124481A1 (no)
DK (1) DK0469440T3 (no)
EG (1) EG19690A (no)
ES (1) ES2058999T3 (no)
FI (1) FI97951C (no)
HK (1) HK15695A (no)
HR (1) HRP920575B1 (no)
HU (1) HU206268B (no)
IE (1) IE66378B1 (no)
IL (1) IL99031A (no)
LT (1) LT3528B (no)
LV (1) LV10043B (no)
MC (1) MC2274A1 (no)
MX (1) MX9100441A (no)
NO (1) NO178252C (no)
NZ (1) NZ239222A (no)
PT (1) PT98532B (no)
RO (1) RO113611B1 (no)
SG (1) SG181694G (no)
SI (1) SI9111342B (no)
SK (2) SK279740B6 (no)
ZA (1) ZA916124B (no)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0804174A4 (en) * 1993-07-21 1998-09-09 Univ Kentucky Res Found MULTI-CHAMBER HARD CAPSULES WITH CONTROLLED DELIVERY CHARACTERISTICS
ITFI970184A1 (it) * 1997-07-30 1999-01-30 Menarini Farma Ind Composizioni farmaceutiche contenenti vitamina d e calcio,loro preparazione ed uso terapeutico
DE19733305A1 (de) * 1997-08-01 1999-02-04 Asta Medica Ag Pharmazeutische Zusammensetzung enthaltend Ifosfamid und Carnitin
US6103297A (en) * 1998-01-14 2000-08-15 Matsushita Electronics Corporation Method of manufacturing cathode-ray tube
DE19826517B4 (de) * 1998-06-15 2006-03-23 Baxter Healthcare S.A. Verfahren zur Herstellung von Filmtabletten mit Cyclophosphamid als Wirkstoff und daraus hergestellte Cyclophosphamid-Filmtablette
US20040253307A1 (en) * 2003-02-04 2004-12-16 Brian Hague Sugar-free oral transmucosal solid dosage forms and uses thereof
DE102005008797A1 (de) * 2005-02-25 2006-09-07 Baxter International Inc., Deerfield Trofosfamid-haltige Filmtabletten und Verfahren zu deren Herstellung
CN106413706A (zh) 2014-01-06 2017-02-15 铁治疗控股公司 三麦芽酚铁的剂量方案
GB201418710D0 (en) 2014-10-21 2014-12-03 Iron Therapeutics Holdings Ag Dosage regimen

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS5646807A (en) * 1979-09-27 1981-04-28 Japan Atom Energy Res Inst Production of composition of complex gradually releasing physiologically active substance
DE3111428A1 (de) * 1981-03-24 1982-10-07 Asta-Werke Ag, Chemische Fabrik, 4800 Bielefeld Oxazaphosphorin-4-thio-alkansulfonsaeuren und deren neutrale salze, verfahren zu ihrer herstellung und diese enthaltende pharmazeutische zubereitungen
US4618692A (en) * 1981-09-03 1986-10-21 Asta-Werke Aktiengesellschaft 4-carbamoyloxy-oxazaphosphorins
US5019385A (en) * 1984-11-09 1991-05-28 Kabushiki Kaisha Hayashibara Seibutsu Kagaku Kenkyujo Novel lymphopine LK 2 and pharmaceutic compositions containing same
DE3722043A1 (de) * 1986-07-11 1988-01-14 Asta Werke Ag Chem Fab Loesungen von oxazaphosphorinen mit verbesserter stabilitaet und verfahren zu deren herstellung
DE3804686A1 (de) * 1988-02-15 1989-08-24 Henkel Kgaa Arzneimittel mit einer kombination von cytostatika bzw. hormontherapeutika und phosphonoderivaten

Also Published As

Publication number Publication date
CZ280475B6 (cs) 1996-01-17
SK279740B6 (sk) 1999-03-12
AR247484A1 (es) 1995-01-31
JP3545300B2 (ja) 2004-07-21
IE912774A1 (en) 1992-02-12
SK279739B6 (sk) 1999-03-12
CS240991A3 (en) 1992-03-18
AU8158991A (en) 1992-02-06
HK15695A (en) 1995-02-10
MC2274A1 (fr) 1993-06-23
NO178252B (no) 1995-11-13
IE66378B1 (en) 1995-12-27
ATE110261T1 (de) 1994-09-15
MX9100441A (es) 1992-04-01
HU912594D0 (en) 1992-01-28
LV10043B (en) 1995-06-20
JPH04243828A (ja) 1992-08-31
NO178252C (no) 1996-02-21
PT98532B (pt) 1999-01-29
DE4124481A1 (de) 1992-02-06
AU4483693A (en) 1993-11-11
LV10043A (lv) 1994-05-10
AU649184B2 (en) 1994-05-12
KR0177170B1 (ko) 1999-03-20
NO913019L (no) 1992-02-04
HRP920575A2 (en) 1995-04-30
DE59102620D1 (de) 1994-09-29
PT98532A (pt) 1992-06-30
IL99031A (en) 1996-09-04
HU206268B (en) 1992-10-28
IL99031A0 (en) 1992-07-15
SI9111342B (sl) 1998-10-31
CN1058715A (zh) 1992-02-19
AU643309B2 (en) 1993-11-11
DK0469440T3 (da) 1994-11-14
KR920003963A (ko) 1992-03-27
CN1046851C (zh) 1999-12-01
LT3528B (en) 1995-11-27
FI913710A (fi) 1992-02-04
FI913710A0 (fi) 1991-08-02
US5158776A (en) 1992-10-27
CA2048367C (en) 2000-05-23
ES2058999T3 (es) 1994-11-01
HUT59316A (en) 1992-05-28
EG19690A (en) 1995-09-30
ZA916124B (en) 1992-04-29
CA2048367A1 (en) 1992-02-04
NO913019D0 (no) 1991-08-02
SG181694G (en) 1995-05-12
RO113611B1 (ro) 1998-09-30
LTIP921A (en) 1995-03-27
EP0469440A1 (de) 1992-02-05
FI97951C (fi) 1997-03-25
EP0469440B1 (de) 1994-08-24
NZ239222A (en) 1993-01-27
HRP920575B1 (en) 1999-04-30
FI97951B (fi) 1996-12-13
JP2000229860A (ja) 2000-08-22
JP3061898B2 (ja) 2000-07-10
SI9111342A (sl) 1998-04-30

Similar Documents

Publication Publication Date Title
US4842866A (en) Slow release solid preparation
FI92014B (fi) Kiinteä, hallitusti vapauttava lääkeaineen kantoaineena käytettävä matriisi
US5047246A (en) Direct compression cyclophosphamide tablet
EP2133084A2 (en) Pharmaceutical Formulation Comprising Lanthanum Compounds
JPS62292733A (ja) 徐放性医薬組成物
AT5874U1 (de) Pharmazeutische zubereitungen enthaltend amlodipinmaleat
CZ314899A3 (cs) Farmaceutický prostředek
BG60900B1 (bg) Твърди лекарствени форми за орално приложение,съдържащи ифосфамид като активно вещество
CN1041797C (zh) 提高了生物利用率的活性物质氯甲双磷酸的片剂
HU199073B (en) Process for production of improved medical compositions containing flunarizine
US5035898A (en) Potassium/magnesium supplement
SK18582000A3 (sk) Obalené cyklofosfamidové tablety
EP0319074B1 (en) Pharmaceutical composition and process for its preparation
KR20190110771A (ko) 데페라시록스를 함유하는 소형 분산성 정제
CA1229552A (en) Cimetidine compositions
EP1233758A2 (de) Natriumvalproat-granulat mit verringerter hygroskopizität
EP0381182B1 (en) An erosion-controlled release system for active agents and a process for its preparation
RU2039553C1 (ru) Твердая лекарственная форма ифосфамида
KR20190104974A (ko) 에너지보급 및 근무력증 예방 및 개선용 경구투여용 시트룰린 말레이트 고형제제 조성물
RU2183958C1 (ru) Фармацевтическая антимикробная композиция
JPH0840917A (ja) 向上した安全性側面を有する制酸薬調剤
SK15612000A3 (sk) Perorálne tablety s riadeným uvoľňovaním farmaceuticky akceptovateľných solí metoprololu a spôsob ich prípravy